Oral alkalinizing supplementation suppressed intrarenal reactive oxidative stress in mild-stage chronic kidney disease: a randomized cohort study.

Michiaki AbeTakuhiro YamaguchiSeizo KoshibaShin TakayamaToshiki NakaiKoichiro NishiokaSatomi YamasakiKazuhiko KawaguchiMasanori UmeyamaAtsuko MasauraKota IshizawaRyutaro AritaTakeshi KannoTetsuya AkaishiMariko MiyazakiTakaaki AbeTetsuhiro TanakaTadashi Ishiinull null

Published in: Clinical and experimental nephrology (2024)

This study is the first to report supplementation of PCSC reduced intrarenal oxidative stress in patients with mild-stage CKD.

Keyphrases

oxidative stress
chronic kidney disease
end stage renal disease
dna damage
ischemia reperfusion injury
diabetic rats